Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Shares Outstanding (2013 - 2026)

Scynexis' (SCYX) quarterly Shares Outstanding (Entity) came in at $9.9 million in Q2 2026, up 60.0% on a YoY basis from $6.2 million in Q2 2025, and up 56.2% quarter-over-quarter from $6.4 million in Q1 2026.

Analysis

Scynexis (SCYX) Shares Outstanding (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Shares Outstanding (Entity) for 14 consecutive years, with $9.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 60.0% year-over-year to $9.9 million; the trailing twelve-month figure through Jun 2026 stood at $9.9 million (up 60.0% YoY), and the FY2025 full-year result was $5.4 million, down 10.25% from the prior year.
  • Shares Outstanding (Entity) advanced to $9.9 million in Q2 2026 per SCYX's latest filing, from $6.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $9.9 million in Q2 2026 and bottomed at $3.7 million in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $6.0 million across 5 years, with a median of $6.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) surged 98.88% in 2022, then declined 13.7% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $5.3 million in 2022, then rose by 12.29% to $6.0 million in 2023, then increased by 1.38% to $6.1 million in 2024, then slipped by 10.25% to $5.4 million in 2025, then surged by 82.81% to $9.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $9.9 million, $6.4 million, and $5.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 61.30 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 720.78 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 11.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.82 Mn
Mar 31, 2026 6.37 Mn
Dec 31, 2025 6.24 Mn
Sep 30, 2025 6.24 Mn
Jun 30, 2025 6.22 Mn
Mar 31, 2025 6.18 Mn
Dec 31, 2024 6.06 Mn
Sep 30, 2024 6.08 Mn
Jun 30, 2024 6.06 Mn
Mar 31, 2024 6.03 Mn
Dec 31, 2023 5.98 Mn
Sep 30, 2023 5.99 Mn
Jun 30, 2023 5.98 Mn
Mar 31, 2023 5.97 Mn
Dec 31, 2022 5.33 Mn
Sep 30, 2022 5.94 Mn
Jun 30, 2022 5.41 Mn
Mar 31, 2022 4.01 Mn
Dec 31, 2021 3.30 Mn
Sep 30, 2021 3.33 Mn